Representative Matters
代表事项
REFERENZMANDATE
- edX Inc. in its strategic transaction with 2U, Inc.
- Fleetmatics Group PLC in its $2.4 billion sale to Verizon
- AppNexus in its sale to AT&T
- Landmark Bio, in a joint venture formation between Harvard University, Fujifilm Diosynth Biotechnologies, Cytiva, and Alexandria Real Estate Equities
- New Euro-Pro Holdings LLC (d/b/a “SharkNinja”) in an investment by CDH Investments
- 6 River Systems, Inc. in its $450 million sale to Shopify Inc.
- Boston Dynamics in its acquisition by Google, Inc.*
- Continuum Managed Services in its sale to Thoma Bravo, and subsequent sale to ConnectWise, LLC.
- Continuum Managed Services in its acquisitions of BrightGauge Software Inc. and Carvir, LLC
- Steward Health Care Systems LLC in its acquisition of New England Sinai Hospital*
- Sansoro Health, Inc. in its acquisition of Datica Health, Inc.
- Evariant, Inc., in its sale to Healthgrades
- ANSYS, Inc. in its investment in 3DSIM, LLC
- PTC Inc. in its acquisition of Enigma*
- Nova Ventures Group in its acquisitions of multiple portfolio companies in the sensors industry
- Alkermes plc. in its $50 million sale of a division to Recro Pharma, Inc.
- GnuBio Inc. in its sale to Bio-Rad Laboratories, Inc.*
- Viracor-IBT in its $255 million sale to Eurofins Scientific*
- Essilor International in its acquisition of Costa Inc.*
- Perfumania Holdings, Inc. in its registration of securities on Form S-4 in connection with its acquisition of Parlux Fragrances, Inc.*
- Bessemer Venture Partners in investments in early-stage technology companies
- A FinTech investment fund in a wide range of investments into FinTech portfolio companies
- General Catalyst Partners in investments in entrepreneur-in-residence investment vehicles
- Matrix Partners in investments in early-stage technology companies
- Optum Venture Partners in investments in portfolio companies
- Will Ventures in investments in portfolio companies at the intersection of sports and technology
- Romulus Capital in investments in Ceres Imaging, Cogito, Cohealo, Disruptor Beam, E la Carte, EquipmentShare.com, Humanyze, Petagene, Placester, and Vyome Biosciences
- BioInnovation Capital in investments in early-stage life sciences companies
- Flare Capital Partners in its investment in Bright Health
- Charles River Ventures in its Series A investment in a technology company*
- Ascension Ventures in its investments in Atigeo, Inc. and Syapse, Inc.
- Startup Institute in its Series B equity financing
- Open Door Trading LLC in its equity financings
- Alkermes plc in its investment in ReSet Therapeutics, Inc.
- Serenity Pharmaceuticals LLC in its Series C equity financing
- Viamet Pharmaceuticals in its Series C equity financing*
- Asahi Kasei Corporation in its investment in Hydro-Photon, Inc.
- Mr. Reardon co-taught "Forming and Financing a Start-Up Business," a semester-long course in the Transactional Law Program at the Boston University School of Law.
- Mr. Reardon serves as a mentor a judge in the MIT $100K Entrepreneur Competition.
- Mr. Reardon leads mock negotiation sessions for the MIT Sloan School of Management course "Early Stage Capital."
- Mr. Reardon is actively involved in pro bono matters, serving as outside general counsel for THINKMD, Inc., a public benefit corporation that has deployed a free screening assessment and education tool to monitor the COVID-19 pandemic spread and response. Read more about their efforts here.